Drug Reference

Glucosamine

Other antiinflammatory and antirheumatic agents, non-steroids

← All medicines · Other antiinflammatory and antirheumatic agents, non-steroids

OTC

Fact box

Therapeutic class
Other antiinflammatory and antirheumatic agents, non-steroids
Habit forming
No
Availability
Over-the-counter (OTC)

Brand names

CidaflexCosaminNovipet Joint SupportNovipet Magic BitesOptiflex-GOsteo Bi-FlexSchiff

Available as

200 MG · Oral Tablet400 MG · Extended Release Oral Tablet133 MG · Oral Capsule500 UNT · Oral Tablet1200 MG · Oral Tablet500 MG · Oral Tablet40 MG/ML · Oral Solution400 MG · Oral Tablet50 MG · Chewable Tablet750 MG · Oral Tablet500 MG · Oral Capsule150 MG · Oral Tablet500 MG · Chewable Tablet600 MG · Chewable Tablet40 MG/ML · Oral Suspension250 MG · Oral Capsule400 MG · Oral Capsule200 MG · Extended Release Oral Tablet200 MG · Oral Capsule2000 MG · Oral Capsule1200 MG · Oral Capsule750 MG · Oral Capsule1500 MG · Oral Tablet400 MG · Chewable Tablet

FDA label sections are from openFDA and may not reflect the most recent labeling — confirm against the current DailyMed label.

How to use / dosing
Direction Take 2-3 capsules daily, preferably with a meal.

Safety advice

Conservative summary derived from FDA labeling — defaults to “consult your doctor” unless the label is explicit. Not a substitute for your clinician’s advice.

PregnancyNo information
No specific information in the FDA label.
BreastfeedingNo information
No specific information in the FDA label. Check LactMed →
AlcoholNo information
No specific information in the FDA label.
DrivingNo information
No specific information in the FDA label.
KidneyNo information
No specific information in the FDA label.
LiverNo information
No specific information in the FDA label.
Warnings & precautions
Other Ingredients Maize starch, Microcrystalline Cellulose, Magnesium Stearate.
Current FDA labels (DailyMed)

72 marketed products on record (RxNorm)

Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.